中文名称 | 英文名称 | CAS号 | 化学式 | 分子量 |
---|---|---|---|---|
1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸三叔丁酯 | 1,4,7-tris(tert-butoxycarbonylmethyl)-1,4,7,10-tetraazacyclododecane-10-acetic acid | 137076-54-1 | C28H52N4O8 | 572.743 |
1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸四叔丁酯 | tetra-(tert-butoxycarbonylmethyl)-1,4,7,10-tetraazacyclododecane hydrochloride | 585531-74-4 | C32H60N4O8 | 628.85 |
A new dual imaging and therapeutic agent is proposed to improve the efficacy of boron neutron capture therapy in cancer treatment.
Monomolecular multimodal imaging agents (MOMIAs) are able to provide complementary diagnostic information of a target diseased tissue. We developed a convenient solid‐phase approach to construct two pro‐MOMIAs (before incorporating radiometal) derived from 1,4,7,10‐tetraazacy‐clododecane‐1,4,7,10‐tetraacetic acid (DOTA) and cypate, a near‐infrared (NIR) fluorescent dye analogous to indocyanine green (ICG). The possible interaction between d orbitals of transition metal DOTA complexes or free metals and the p orbitals of cypate chromophore could quench the fluorescence of pro‐MOMIAs. However, we did not observe significant changes in the spectral properties of cypate upon conjugation with DOTA and subsequent chelation with metals. The fluorescence intensity of the chelated and nonmetal‐chelated PRO‐MOMIAs remained fairly the same in dilute 20% aqueous dimethylsulfoxide (DMSO) solution (1 × 10−6
A new lipophilic NCT/MRI agent has been synthesised in only four steps and characterised from the relaxometric point of view. This compound shows a high affinity for LDLs that can be loaded with 300 complexes per particle.